Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Titre-specific positive predictive value of antinuclear antibody patterns.

Vulsteke JB, Van Hoovels L, Willems P, Vander Cruyssen B, Vanderschueren S, Westhovens R, Blockmans D, De Langhe E, Bossuyt X.

Ann Rheum Dis. 2019 Oct 10. pii: annrheumdis-2019-216245. doi: 10.1136/annrheumdis-2019-216245. [Epub ahead of print] No abstract available.

PMID:
31601627
2.

First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients with Rheumatoid Arthritis.

Crins MHP, Terwee CB, Westhovens R, van Schaardenburg D, Smits N, Joly J, Verschueren P, Van der Elst K, Dekker J, Boers M, Roorda LD.

Arthritis Care Res (Hoboken). 2019 Sep 28. doi: 10.1002/acr.24077. [Epub ahead of print]

PMID:
31562795
3.

Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.

Bossuyt X, Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Fritzler MJ, Mahler M, Fierz W.

Autoimmun Rev. 2019 Nov;18(11):102386. doi: 10.1016/j.autrev.2019.102386. Epub 2019 Sep 11. No abstract available.

PMID:
31520795
4.

Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa.

Mulumba C, Lebughe P, Mbuyi-Muamba JM, Makulo JR, Lepira F, Mukaya J, Westhovens R, Verschueren P, Malemba JJ.

BMC Rheumatol. 2019 Sep 9;3:37. doi: 10.1186/s41927-019-0085-4. eCollection 2019.

5.

Multi-segment spine and hip kinematics in asymptomatic individuals during standardized return from forward bending versus functional box lifting.

Seerden SFL, Dankaerts W, Swinnen TW, Westhovens R, de Vlam K, Vanwanseele B.

J Electromyogr Kinesiol. 2019 Aug 22;49:102352. doi: 10.1016/j.jelekin.2019.102352. [Epub ahead of print]

PMID:
31473452
6.

Response to Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center.

De Cock D, Vanhoffelen E, Stouten V, Verschueren P, Westhovens R.

Semin Arthritis Rheum. 2019 Jul 13. pii: S0049-0172(19)30161-1. doi: 10.1016/j.semarthrit.2019.06.022. [Epub ahead of print] No abstract available.

PMID:
31353057
7.

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA.

Stouten V, Westhovens R, Pazmino S, De Cock D, Van der Elst K, Joly J, Verschueren P; CareRA study group .

Rheumatology (Oxford). 2019 Jun 24. pii: kez213. doi: 10.1093/rheumatology/kez213. [Epub ahead of print]

PMID:
31236568
8.

Antinuclear antibodies by indirect immunofluorescence and solid phase assays.

Bossuyt X, Claessens J, De Langhe E, Belmondo T, Westhovens R, Hue S, Poesen K, Blockmans D, Mahler M, Fritzler MJ.

Ann Rheum Dis. 2019 May 10. pii: annrheumdis-2019-215443. doi: 10.1136/annrheumdis-2019-215443. [Epub ahead of print] No abstract available.

PMID:
31076390
9.

Patient reported outcome data from the Care in Early Rheumatoid Arthritis trial: Opportunities for broadening the scope of treating to target.

Van der Elst K, Verschueren P, Stouten V, Pazmino S, De Groef A, De Cock D, Joly J, Moons P, Westhovens R.

Arthritis Care Res (Hoboken). 2019 Apr 5. doi: 10.1002/acr.23900. [Epub ahead of print]

PMID:
30951267
10.

European Qualitative research project on Patient-preferred outcomes in Early Rheumatoid Arthritis (EQPERA): rationale, design and methods of a multinational, multicentre, multilingual, longitudinal qualitative study.

Van der Elst K, Bremander A, De Groef A, Larsson I, Mathijssen EGE, Vriezekolk JE, Westhovens R, van Eijk-Hustings YJL.

BMJ Open. 2019 Mar 27;9(3):e023606. doi: 10.1136/bmjopen-2018-023606.

11.

Mobile Health Features Supporting Self-Management Behavior in Patients With Chronic Arthritis: Mixed-Methods Approach on Patient Preferences.

Geuens J, Geurts L, Swinnen TW, Westhovens R, Vanden Abeele V.

JMIR Mhealth Uhealth. 2019 Mar 25;7(3):e12535. doi: 10.2196/12535.

12.

Clinical efficacy of new JAK inhibitors under development. Just more of the same?

Westhovens R.

Rheumatology (Oxford). 2019 Feb 1;58(Supplement_1):i27-i33. doi: 10.1093/rheumatology/key256.

13.

Treatment adherence in systemic sclerosis: A cross-sectional study.

Brijs J, Arat S, Westhovens R, Lenaerts JL, De Langhe E.

Musculoskeletal Care. 2019 Mar;17(1):44-53. doi: 10.1002/msc.1363. Epub 2018 Oct 9.

PMID:
30298974
14.

Rituximab in systemic autoimmune rheumatic diseases: indications and practical use.

Berghen N, Vulsteke JB, Westhovens R, Lenaerts J, De Langhe E.

Acta Clin Belg. 2019 Aug;74(4):272-279. doi: 10.1080/17843286.2018.1521904. Epub 2018 Sep 26.

PMID:
30253707
15.

Improvements in productivity and increased participation in daily activities over 52 weeks of certolizumab pegol treatment of rheumatoid arthritis: results of a Belgian observational study.

Westhovens R, Ravelingien I, Vandevyvere K, Pansar I, Purcaru O, Kumke T, Gyselbrecht L.

Acta Clin Belg. 2019 Oct;74(5):342-350. doi: 10.1080/17843286.2018.1509923. Epub 2018 Aug 30.

PMID:
30160189
16.

Widespread pain in axial spondyloarthritis: clinical importance and gender differences.

Swinnen TW, Westhovens R, Dankaerts W, de Vlam K.

Arthritis Res Ther. 2018 Jul 27;20(1):156. doi: 10.1186/s13075-018-1626-8.

17.

A multi-criteria decision approach for ranking unmet needs in healthcare.

Cleemput I, Devriese S, Kohn L, Westhovens R.

Health Policy. 2018 Aug;122(8):878-884. doi: 10.1016/j.healthpol.2018.06.010. Epub 2018 Jun 30.

PMID:
29983193
18.

Antinuclear antibody as entry criterion for classification of systemic lupus erythematosus: pitfalls and opportunities.

Willems P, De Langhe E, Westhovens R, Vanderschueren S, Blockmans D, Bossuyt X.

Ann Rheum Dis. 2019 Aug;78(8):e76. doi: 10.1136/annrheumdis-2018-213821. Epub 2018 Jun 23. No abstract available.

PMID:
29936439
19.

Spondyloarthritis in the Democratic Republic of the Congo: a prospective hospital-based study.

Lebughe P, de Vlam K, Westhovens R, Mbuyi-Muamba JM, Malemba JJ.

BMJ Open. 2018 May 9;8(5):e020329. doi: 10.1136/bmjopen-2017-020329.

20.

Conversion to seronegative status after abatacept treatment in patients with early and poor prognostic rheumatoid arthritis is associated with better radiographic outcomes and sustained remission: post hoc analysis of the AGREE study.

Jansen DTSL, Emery P, Smolen JS, Westhovens R, Le Bars M, Connolly SE, Ye J, Toes REM, Huizinga TWJ.

RMD Open. 2018 Mar 30;4(1):e000564. doi: 10.1136/rmdopen-2017-000564. eCollection 2018.

21.

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes.

Genovese M, Westhovens R, Meuleners L, Van der Aa A, Harrison P, Tasset C, Kavanaugh A.

Arthritis Res Ther. 2018 Mar 23;20(1):57. doi: 10.1186/s13075-018-1541-z.

22.

Solid phase assays versus automated indirect immunofluorescence for detection of antinuclear antibodies.

Claessens J, Belmondo T, De Langhe E, Westhovens R, Poesen K, Hüe S, Blockmans D, Mahler M, Fritzler MJ, Bossuyt X.

Autoimmun Rev. 2018 Jun;17(6):533-540. doi: 10.1016/j.autrev.2018.03.002. Epub 2018 Mar 8. Review.

PMID:
29526634
23.

Cardiac transplantation in systemic sclerosis: single-centre experience of three cases.

Lenaerts JC, Lenaerts JL, Westhovens R, Droogne W, Ciarka A, Van Cleemput J, De Langhe E.

Rheumatology (Oxford). 2018 Jun 1;57(6):1120-1122. doi: 10.1093/rheumatology/key048. No abstract available.

PMID:
29522189
24.

Prospective associations between illness perceptions and health outcomes in patients with systemic sclerosis and systemic lupus erythematosus: a cross-lagged analysis.

Arat S, Rassart J, Moons P, Luyckx K, Vandenberghe J, Westhovens R.

Rheumatol Adv Pract. 2018 Mar 6;2(1):rky007. doi: 10.1093/rap/rky007. eCollection 2018.

25.

High prevalence of occupational exposure to solvents or silica in male systemic sclerosis patients: a Belgian cohort analysis.

De Decker E, Vanthuyne M, Blockmans D, Houssiau F, Lenaerts J, Westhovens R, Nemery B, De Langhe E.

Clin Rheumatol. 2018 Jul;37(7):1977-1982. doi: 10.1007/s10067-018-4045-y. Epub 2018 Feb 23.

PMID:
29476353
26.

Illness Identity in Adults with a Chronic Illness.

Oris L, Luyckx K, Rassart J, Goubert L, Goossens E, Apers S, Arat S, Vandenberghe J, Westhovens R, Moons P.

J Clin Psychol Med Settings. 2018 Dec;25(4):429-440. doi: 10.1007/s10880-018-9552-0.

PMID:
29468569
27.

Detection of myositis-specific antibodies.

Vulsteke JB, De Langhe E, Claeys KG, Dillaerts D, Poesen K, Lenaerts J, Westhovens R, Van Damme P, Blockmans D, De Haes P, Bossuyt X.

Ann Rheum Dis. 2019 Jan;78(1):e7. doi: 10.1136/annrheumdis-2017-212915. Epub 2018 Jan 25. No abstract available.

PMID:
29371203
28.

Modifiable correlates of illness perceptions in adults with chronic somatic conditions: A systematic review.

Arat S, De Cock D, Moons P, Vandenberghe J, Westhovens R.

Res Nurs Health. 2018 Apr;41(2):173-184. doi: 10.1002/nur.21852. Epub 2018 Jan 9. Review.

PMID:
29315678
29.

Screening for connective tissue disease-associated antibodies by automated immunoassay.

Willems P, De Langhe E, Claessens J, Westhovens R, Van Hoeyveld E, Poesen K, Vanderschueren S, Blockmans D, Bossuyt X.

Clin Chem Lab Med. 2018 May 24;56(6):909-918. doi: 10.1515/cclm-2017-0905.

PMID:
29306915
30.

Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial.

Bandyopadhyay S, Connolly SE, Jabado O, Ye J, Kelly S, Maldonado MA, Westhovens R, Nash P, Merrill JT, Townsend RM.

Lupus Sci Med. 2017 Jul 28;4(1):e000206. doi: 10.1136/lupus-2017-000206. eCollection 2017.

31.

Illness representations of systemic lupus erythematosus and systemic sclerosis: a comparison of patients, their rheumatologists and their general practitioners.

Arat S, Lenaerts JL, De Langhe E, Verschueren P, Moons P, Vandenberghe J, Taelman V, Westhovens R.

Lupus Sci Med. 2017 Nov 14;4(1):e000232. doi: 10.1136/lupus-2017-000232. eCollection 2017.

32.

Activity Limitations in Patients with Axial Spondyloarthritis: A Role for Fear of Movement and (Re)injury Beliefs.

Swinnen TW, Vlaeyen JWS, Dankaerts W, Westhovens R, de Vlam K.

J Rheumatol. 2018 Mar;45(3):357-366. doi: 10.3899/jrheum.170318. Epub 2017 Nov 15.

PMID:
29142031
33.

The use of glucocorticoids in early rheumatoid arthritis.

Verschueren P, Westhovens R.

Rheumatology (Oxford). 2018 Aug 1;57(8):1316-1317. doi: 10.1093/rheumatology/kex271. Review. No abstract available.

PMID:
28968687
34.

Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.

van Overbeeke E, De Beleyr B, de Hoon J, Westhovens R, Huys I.

BioDrugs. 2017 Oct;31(5):447-459. doi: 10.1007/s40259-017-0244-3.

PMID:
28929342
35.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
36.

The Dutch-Flemish PROMIS Physical Function item bank exhibited strong psychometric properties in patients with chronic pain.

Crins MHP, Terwee CB, Klausch T, Smits N, de Vet HCW, Westhovens R, Cella D, Cook KF, Revicki DA, van Leeuwen J, Boers M, Dekker J, Roorda LD.

J Clin Epidemiol. 2017 Jul;87:47-58. doi: 10.1016/j.jclinepi.2017.03.011. Epub 2017 Mar 28.

PMID:
28363734
37.

A Rare Cause of Weight Loss in an 80y Old Ankylosing Spondylitis Patient.

Westhovens I, Thielens I, De Vlam K, Westhovens R, Delva T.

J Clin Rheumatol. 2017 Apr;23(3):170-171. doi: 10.1097/RHU.0000000000000505. No abstract available.

PMID:
28277346
38.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.

39.

Diverging illness perceptions between physicians about patients with systemic lupus erythematosus and systemic sclerosis: a vignette-based study.

Arat S, Moons P, Vandenberghe J, Lenaerts JL, de Vlam K, Westhovens R.

Rheumatol Int. 2017 Jun;37(6):915-922. doi: 10.1007/s00296-017-3667-8. Epub 2017 Feb 28.

PMID:
28246961
40.

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases.

Billiet L, Swinnen TW, Westhovens R, de Vlam K, Van Huffel S.

Sensors (Basel). 2016 Dec 16;16(12). pii: E2151. doi: 10.3390/s16122151.

41.

Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1).

Westhovens R, Taylor PC, Alten R, Pavlova D, Enríquez-Sosa F, Mazur M, Greenwald M, Van der Aa A, Vanhoutte F, Tasset C, Harrison P.

Ann Rheum Dis. 2017 Jun;76(6):998-1008. doi: 10.1136/annrheumdis-2016-210104. Epub 2016 Dec 19.

42.

A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.

De Mits S, Lenaerts J, Vander Cruyssen B, Mielants H, Westhovens R, Durez P, Elewaut D; Be-Raise study group.

PLoS One. 2016 Nov 28;11(11):e0166607. doi: 10.1371/journal.pone.0166607. eCollection 2016.

43.

A Review of Persuasive Principles in Mobile Apps for Chronic Arthritis Patients: Opportunities for Improvement.

Geuens J, Swinnen TW, Westhovens R, de Vlam K, Geurts L, Vanden Abeele V.

JMIR Mhealth Uhealth. 2016 Oct 13;4(4):e118.

44.

Costs of drugs for treatment of rheumatic diseases.

Westhovens R, Annemans L.

RMD Open. 2016 Sep 12;2(2):e000259. doi: 10.1136/rmdopen-2016-000259. eCollection 2016.

45.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.

Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1. Review.

PMID:
27491568
46.

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.

PMID:
27432356
47.

Instrumented BASFI (iBASFI) Shows Promising Reliability and Validity in the Assessment of Activity Limitations in Axial Spondyloarthritis.

Swinnen TW, Milosevic M, Van Huffel S, Dankaerts W, Westhovens R, de Vlam K.

J Rheumatol. 2016 Aug;43(8):1532-40. doi: 10.3899/jrheum.150439. Epub 2016 Jun 15. Erratum in: J Rheumatol. 2016 Aug;43(8):1618.

PMID:
27307537
48.

Development and preliminary evaluation of the validity and reliability of a revised illness perception questionnaire for healthcare professionals.

Arat S, Van den Zegel A, Van Rillaer M, Moons P, Vandenberghe J, De Langhe E, Westhovens R.

BMC Nurs. 2016 Jun 1;15:34. doi: 10.1186/s12912-016-0156-4. eCollection 2016.

49.

Separately tackling the development of erosions with denosumab: ultimately closing a gap in the treatment of patients with rheumatoid arthritis or trying too hard too late?

Verschueren P, Westhovens R.

Ann Rheum Dis. 2016 Jun;75(6):947-9. doi: 10.1136/annrheumdis-2015-208863. Epub 2016 Feb 9. No abstract available.

PMID:
26861701
50.

Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study.

van der Elst K, Meyfroidt S, De Cock D, De Groef A, Binnard E, Moons P, Verschueren P, Westhovens R.

Arthritis Care Res (Hoboken). 2016 Sep;68(9):1278-87. doi: 10.1002/acr.22824. Epub 2016 Jul 29.

Supplemental Content

Loading ...
Support Center